Incidence of clinical lipodystrophy in HIV-1-infected patients treated during primary infection

AIDS

Volumn 15, Issue 2, 2001, Pages 282-284

  Goujard, C ^a   Boufassa, F ^a   Deveau, C ^a   Laskri, D ^a   Meyer, L ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHOLESTEROL; DIDANOSINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INDINAVIR; LAMIVUDINE; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; STAVUDINE;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INCIDENCE; LIPODYSTROPHY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; SYMPTOMATOLOGY;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; INCIDENCE; LIPODYSTROPHY; MALE;

EID: 0035951492     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200101260-00024     Document Type: Article

References (2)

1. Fat distribution and metabolic changes in patients with HIV infection
2. Weak anti-HIV CD8+ T-cell effector activity in HIV primary infection